Spinal Anaesthesia for Knee Arthroscopy: Does Lignocaine Shorten the Effect of Bupivacaine
Information source: Frederikssunds Hospital, Denmark
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Spinal Anesthesia
Intervention: Lidocaine (Drug); bupivacaine (Drug)
Phase: Phase 4
Status: Completed
Sponsored by: Frederikssunds Hospital, Denmark Official(s) and/or principal investigator(s):
Jon Jacobsen, M.D., Principal Investigator, Affiliation: Frederikssunds Hospital, Denmark
Summary
The purpose of the study is to investigate if a small amount of lignocaine added to
bupivacaine for spinal anesthesia to patients planned for arthroscopic knee surgery, can
shorten the duration of the sensoric and the motoric blockade.
Clinical Details
Official title: Spinal Anaesthesia for Knee Arthroscopy: Does Lignocaine Shorten the Effect of Bupivacaine?
Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Primary outcome: Duration of spinal blockade
Secondary outcome: Time to fulfillment of discharge criteria from the hospital.
Eligibility
Minimum age: 18 Years.
Maximum age: 65 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- The patient want spinal anaesthesia
- No contradictions against spinal anaesthesia
- Healthy people (ASA-score 1 or 2)
- Body mass index < 35 and between 155 and 190 cm
Exclusion Criteria:
- Known allergic reactions to planned drugs
- Neurologic disturbances
- Diabetes
Locations and Contacts
Dep. of anesthesiology, Hospital of Frederikssund, Frederikssund 3600, Denmark
Jon Jacobsen, Frederikssund DK 3600, Denmark
Additional Information
Starting date: November 2009
Last updated: May 7, 2015
|
